726 related articles for article (PubMed ID: 7655375)
21. Role of allogenic bone marrow transplantation in adolescent or adult patients with acute lymphoblastic leukaemia or lymphoblastic lymphoma in first remission.
De Witte T; Awwad B; Boezeman J; Schattenberg A; Muus P; Raemaekers J; Preijers F; Strijckmans P; Haanen C
Bone Marrow Transplant; 1994 Nov; 14(5):767-74. PubMed ID: 7889010
[TBL] [Abstract][Full Text] [Related]
22. Autologous bone marrow transplantation for treatment of isolated central nervous system relapse of childhood acute lymphoblastic leukemia. AIEOP/FONOP-TMO group. Associzione Italiana Emato-Oncologia Pediatrica.
Messina C; Valsecchi MG; Aricò M; Locatelli F; Rossetti F; Rondelli R; Cesaro S; Uderzo C; Conter V; Pession A; Sotti G; Loiacono G; Santoro N; Miniero R; Dini G; Favre C; Meloni G; Testi AM; Werner B; Silvestri D; Arrighini A; Varotto S; Pillon M; Basso G; Zanesco L
Bone Marrow Transplant; 1998 Jan; 21(1):9-14. PubMed ID: 9486488
[TBL] [Abstract][Full Text] [Related]
23. Allogeneic bone marrow transplantation for children with acute leukemia: long-term follow-up of patients prepared with high-dose cytosine arabinoside and fractionated total body irradiation.
Gordon BG; Warkentin PI; Strandjord SE; Abromowitch M; Bayever E; Harper JL; Coccia PF
Bone Marrow Transplant; 1997 Jul; 20(1):5-10. PubMed ID: 9232249
[TBL] [Abstract][Full Text] [Related]
24. Allogeneic or autologous bone marrow transplantation for acute lymphoblastic leukemia in first complete remission.
Blaise D; Gaspard MH; Stoppa AM; Michel G; Gastaut JA; Lepeu G; Tubiana N; Blanc AP; Rossi JF; Novakovitch G
Bone Marrow Transplant; 1990 Jan; 5(1):7-12. PubMed ID: 2404531
[TBL] [Abstract][Full Text] [Related]
25. Bone marrow transplantation in 63 adult patients with acute lymphoblastic leukemia in first complete remission.
Vey N; Blaise D; Stoppa AM; Bouabdallah R; Lafage M; Sainty D; Cowen D; Viens P; Lepeu G; Blanc AP
Bone Marrow Transplant; 1994 Sep; 14(3):383-8. PubMed ID: 7994259
[TBL] [Abstract][Full Text] [Related]
26. Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes.
Slavin S; Naparstek E; Nagler A; Ackerstein A; Kapelushnik J; Or R
Exp Hematol; 1995 Dec; 23(14):1553-62. PubMed ID: 8542946
[TBL] [Abstract][Full Text] [Related]
27. Outcome in children with relapsed acute myeloid leukemia after initial treatment with the French Leucemie Aique Myeloide Enfant (LAME) 89/91 protocol of the French Society of Pediatric Hematology and Immunology.
Aladjidi N; Auvrignon A; Leblanc T; Perel Y; Bénard A; Bordigoni P; Gandemer V; Thuret I; Dalle JH; Piguet C; Pautard B; Baruchel A; Leverger G;
J Clin Oncol; 2003 Dec; 21(23):4377-85. PubMed ID: 14645428
[TBL] [Abstract][Full Text] [Related]
28. Allogeneic BMT vs. chemotherapy in late bone marrow relapsed childhood non-T/non-B ALL: results of BFM ALL relapse studies. BFM Relapse Study Group.
Schmid H; von Schenck U; Hartmann R; Borgmann A; Henze G
Bone Marrow Transplant; 1996 Nov; 18 Suppl 2():28-30. PubMed ID: 8932794
[TBL] [Abstract][Full Text] [Related]
29. Outcome of very late relapse in children with acute lymphoblastic leukemia.
Rizzari C; Valsecchi MG; Aricò M; Miniero R; Messina C; De Rossi G; Testi AM; Mura R; Galimberti S; Biondi A; Locatelli F; Conter V
Haematologica; 2004 Apr; 89(4):427-34. PubMed ID: 15075076
[TBL] [Abstract][Full Text] [Related]
30. Case-control analysis of allogeneic bone marrow transplantation versus maintenance chemotherapy for relapsed ALL in children.
Hoogerbrugge PM; Gerritsen EJ; vd Does-van den Berg A; vd Berg H; Zwinderman AH; Hermans J; Vossen JM
Bone Marrow Transplant; 1995 Feb; 15(2):255-9. PubMed ID: 7773215
[TBL] [Abstract][Full Text] [Related]
31. Fractionated total body irradiation and high-dose VP-16 with purged autologous bone marrow rescue for children with high risk relapsed acute lymphoblastic leukemia.
Schmid H; Henze G; Schwerdtfeger R; Baumgarten E; Besserer A; Scheffler A; Serke S; Zingsem J; Siegert W
Bone Marrow Transplant; 1993 Dec; 12(6):597-602. PubMed ID: 8136744
[TBL] [Abstract][Full Text] [Related]
32. Allogeneic bone marrow transplantation following a busulfan-based conditioning regimen in young children with acute lymphoblastic leukemia: a Cooperative Study of the Société Française de Greffe de Moelle.
von Bueltzingsloewen A; Esperou-Bourdeau H; Souillet G; Demeocq F; Mechinaud-Lacroix F; Michel G; Sadoun A; Bernaudin F; Cornu G; Donadieu J
Bone Marrow Transplant; 1995 Oct; 16(4):521-7. PubMed ID: 8528167
[TBL] [Abstract][Full Text] [Related]
33. Allogeneic bone marrow transplantation in second remission of childhood acute lymphoblastic leukemia: a population-based case control study from the Nordic countries.
Schroeder H; Gustafsson G; Saarinen-Pihkala UM; Glomstein A; Jonmundsson G; Nysom K; Ringdén O; Mellander L
Bone Marrow Transplant; 1999 Mar; 23(6):555-60. PubMed ID: 10217185
[TBL] [Abstract][Full Text] [Related]
34. Allogeneic bone marrow transplantation in first remission for children with very high-risk acute lymphoblastic leukemia: a retrospective case-control study in the Nordic countries. Nordic Society for Pediatric Hematology and Oncology (NOPHO).
Saarinen UM; Mellander L; Nysom K; Ringden O; Schroeder H; Glomstein A; Gustafsson G
Bone Marrow Transplant; 1996 Mar; 17(3):357-63. PubMed ID: 8704687
[TBL] [Abstract][Full Text] [Related]
35. Allogeneic bone marrow transplantation versus chemotherapy in the treatment of childhood acute lymphoblastic leukemia in second complete remission.
Torres A; Martínez F; Gómez P; Fornés G; Rojas R; Herrera C; Gómez JL; Manzanares R; García JM; Andres P
Bone Marrow Transplant; 1989 Nov; 4(6):609-12. PubMed ID: 2819281
[TBL] [Abstract][Full Text] [Related]
36. [Intensive post-remission therapy in acute myeloid leukemia. Results of a prospective comparative study by the South Germany Hemoblastosis Group].
Hübner G; Link H; Schönrock-Nabulsi P; Wandt H; Gramatzki M; Löffler B; Fackler-Schwalbe I; Queisser W; Brack N; Geer T; Raab M; Ohl S; Schneider B; Schneider C; Freund M; Poliwoda H; Ehninger G
Med Klin (Munich); 1996 Apr; 91 Suppl 3():26-32. PubMed ID: 8692115
[TBL] [Abstract][Full Text] [Related]
37. [Allogenic transplantation of hematopoietic stem cells in the treatment of children with high-risk acute leukemia].
Starý J; Kobylka P; Sedlácek P; Komrska V; Vávra V; Syrůcková Z; Smísek P; Hrubá A; Korínková P; Matĕjková E; Cukrová V; Dolezalová L; Loudová M; Sejkorová J; Kvĕch J
Cas Lek Cesk; 1998 Jun; 137(12):363-7. PubMed ID: 9721472
[TBL] [Abstract][Full Text] [Related]
38. [Acute lymphoblastic leukemias off therapy: course of 80 cases after treatment cessation].
Sánchez Fayos J; Bernacer M; Olavarría E; Outeiriño J; Prieto E; Román A; Pacho E; Villalobos E; Pérez A; Myric A
Sangre (Barc); 1992 Dec; 37(6):439-47. PubMed ID: 1293795
[TBL] [Abstract][Full Text] [Related]
39. [Allogeneic bone marrow transplantation in children with acute lymphoblastic leukemia].
Maldonado MS; Otheo de Tejada E; Muñoz Villa A; García Laraña J
Sangre (Barc); 1993 Feb; 38(1):13-6. PubMed ID: 8470031
[TBL] [Abstract][Full Text] [Related]
40. The TAM regimen prior to allogeneic and autologous bone marrow transplantation for high-risk acute lymphoblastic leukemias: a cooperative study of 62 patients.
Cahn JY; Bordigoni P; Souillet G; Pico JL; Plouvier E; Reiffers J; Benz-Lemoine E; Bergerat JP; Lutz P; Colombat P
Bone Marrow Transplant; 1991 Jan; 7(1):1-4. PubMed ID: 2043871
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
